KELOWNA, BC, Jan. 14, 2021 /CNW/ - The Valens Company Inc.
(TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens
Company"), a leading manufacturer of cannabis
derivative products, announced today that it has become an
Associate Corporate Member of Food, Health & Consumer Products
of Canada (FHCP), the largest
voice of the Canadian food, beverage and consumer products industry
representing small independently and privately-owned companies as
well as large, global multinationals, all of whom manufacture and
distribute safe and high-quality consumer packaged goods (CPG) in
Canada.
![The Valens Company Logo (CNW Group/The Valens Company) The Valens Company Logo (CNW Group/The Valens Company)](https://mma.prnewswire.com/media/1420336/The_Valens_Company_The_Valens_Company_Joins_the_Largest_Voice_of.jpg)
As the leading voice uniting companies, large and small, that
provide access to the food, health, and consumer products that
Canadians rely on every day, FHCP works to create a favourable
business environment that allows its members to bring innovative
products to market, promotes environmental stewardship, and
standardizes product labelling so that Canadians have choices and
ready access to world-leading safe and high-quality products.
Joining FHCP is a natural progression for Valens in establishing
a broader CPG footprint and bringing about efforts to normalize
cannabinoid products, which now include various health and wellness
formats such as beverages and bath and beauty products, beyond what
current consumers expect.
"As the only cannabis company in FHCP, our aim is to build out
the category using data-driven consumer insights and respond to
consumer needs in medical, recreational as well as health and
wellness segments," said Tyler
Robson, Chief Executive Officer of The Valens Company. "With
Cannabis 2.0 and now Cannabis 3.0 products entering the market, we
are working to create space within the CPG category where cannabis
is part of the conversation. Consumers are already there, which
just makes our membership with the FHCP a natural fit to their work
and mission."
The relationship with FHCP will allow Valens the opportunity to
create strategic category-building connections with over one
hundred of Canada's top CPG
companies while allowing the Company to educate FHCP members about
the benefits of not only major but also minor, non-intoxicating
cannabinoids. As a member, The Valens Company will have
opportunities to work with CPG peers and facilitate discussion
through seminars, workshops, and presentations. The Company will
also rely on its extensive experience in cannabinoid research,
product development, and large-scale manufacturing, and work with
FHCP to develop consumer and trade insights for companies looking
to learn more about the cannabis industry.
"Our mission at FHCP is to create and shape a competitive
operating environment that fosters innovation and growth for our
members, which includes developing categories such as high-quality
cannabinoid-based products," said Michael
Graydon, Chief Executive Officer of FHCP. "Valens'
membership will serve both to educate our members as well as bring
cannabis and cannabis products into the conversation when it comes
to things like policy discussions, safety and standards, and we're
excited to have them on board."
About The Valens Company
The Valens Company is a leading manufacturer of cannabis
derivative products with a mission to bring the benefits of
cannabis to the world. The Company provides proprietary cannabis
processing services across five core technologies, in addition to
best-in-class product development, formulation and manufacturing of
cannabis consumer packaged goods. The Valens Company's high-quality
products are exclusively formulated for the medical, therapeutic,
health and wellness, and recreational consumer segments, and are
offered across numerous product formats, including oils, vapes,
concentrates, edibles and topicals, as well as pre-rolls, with a
focus on next-generation product development and innovation. Its
breakthrough patented emulsification technology, SōRSE™ by Valens,
converts cannabis oil into water-soluble emulsions for seamless
integration into a variety of product formats, allowing for
near-perfect dosing, stability, and taste. In partnership with
brand houses, consumer packaged goods companies and licensed
cannabis producers around the globe, the Company continues to grow
its diverse product portfolio in alignment with evolving cannabis
consumer preferences in key markets. Through its wholly owned
subsidiary Valens Labs Ltd., the Company is setting the standard in
cannabis testing and research and development with Canada's only ISO17025 accredited analytical
services lab, named The Centre of Excellence in Plant-Based Science
by partner and scientific world leader Thermo Fisher Scientific.
Discover more on The Valens Company and its subsidiaries at
http://www.thevalenscompany.com.
Notice regarding Forward Looking Statements
All information included in this press release, including any
information as to the future financial or operating performance and
other statements of The Valens Company that express management's
expectations or estimates of future performance, other than
statements of historical fact, constitute forward-looking
information or forward-looking statements within the meaning of
applicable securities laws and are based on expectations, estimates
and projections as of the date hereof. Forward-looking statements
are included for the purpose of providing information about
management's current expectations and plans relating to the future.
Wherever possible, words such as "plans", "expects", "scheduled",
"trends", "forecasts", "future", "indications", "potential",
"estimates", "predicts", "anticipate", "to establish", "believe",
"intend", "ability to", or statements that certain actions, events
or results "may", "should", "could", "would", "might", "will", or
are "likely" to be taken, occur or be achieved, or the negative of
these words or other variations thereof, have been used to identify
such forward-looking information. Specific forward-looking
statements include, without limitation, all disclosure regarding
future results of operations, economic conditions and anticipated
courses of action. Investors and other parties are advised that
there is not necessarily any correlation between the number of SKUs
manufactured and shipped and revenue and profit, and undue reliance
should not be placed on such information.
The risks and uncertainties that may affect forward-looking
statements include, among others, Canadian regulatory risk,
Australian regulatory risk, U.S. regulatory risk, U.S. border
crossing and travel bans, the uncertainties, effects of and
responses to the COVID-19 pandemic, reliance on licenses, expansion
of facilities, competition, dependence on supply of cannabis and
reliance on other key inputs, dependence on senior management and
key personnel, general business risk and liability, regulation of
the cannabis industry, change in laws, regulations and guidelines,
compliance with laws, reliance on a single facility, limited
operating history, vulnerability to rising energy costs,
unfavourable publicity or consumer perception, product liability,
risks related to intellectual property, product recalls,
difficulties with forecasts, management of growth and litigation,
many of which are beyond the control of The Valens Company. For a
more comprehensive discussion of the risks faced by The Valens
Company, and which may cause the actual financial results,
performance or achievements of The Valens Company to be materially
different from estimated future results, performance or
achievements expressed or implied by forward-looking information or
forward-looking statements, please refer to The Valens Company's
latest Annual Information Form filed with Canadian securities
regulatory authorities at www.sedar.com or on The Valens Company's
website at www.thevalenscompany.com. The risks described in such
Annual Information Form are hereby incorporated by reference
herein. Although the forward-looking statements contained herein
reflect management's current beliefs and reasonable assumptions
based upon information available to management as of the date
hereof, The Valens Company cannot be certain that actual results
will be consistent with such forward-looking information. The
Valens Company cautions you not to place undue reliance upon any
such forward-looking statements. The Valens Company disclaims any
intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise, except as required by applicable law. Nothing herein
should be construed as either an offer to sell or a solicitation to
buy or sell securities of The Valens Company.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/the-valens-company-joins-the-largest-voice-of-the-cpg-industry-in-the-country--food-health--consumer-products-fhcp-of-canada-301208008.html
SOURCE The Valens Company